Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Theraclion SA の最大収益セグメントは Consumables で、最新の利益発表における収益は 484,000 です。地域別に見ると、Germany, China, Hong Kong, Macao and United Kingdom が Theraclion SA の主要市場であり、収益は 830,209 です。